tiprankstipranks
TriSalus Life Sciences (TLSI)
NASDAQ:TLSI
US Market
Holding TLSI?
Track your performance easily

TriSalus Life Sciences (TLSI) Financial Statements

27 Followers

TriSalus Life Sciences Financial Overview

TriSalus Life Sciences's market cap is currently ―. The company's EPS TTM is $-2.511; its P/E ratio is -1.78; TriSalus Life Sciences is scheduled to report earnings on November 14, 2024, and the estimated EPS forecast is $-0.35. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue$ 7.36M$ 6.46M$ 13.32M$ 5.19M$ 4.61M
Gross Profit$ 6.45M$ 5.49M$ 11.30M$ 4.60M$ 3.84M
EBIT$ -3.45M$ -13.21M$ -35.51M$ -1.28M$ -13.96M
EBITDA$ -2.76M$ -12.95M$ -35.30M$ -1.28M$ -13.82M
Net Income Common Stockholders$ -5.13M$ -14.02M$ -60.09M$ -1.74M$ -16.00M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 16.48M$ 3.97M$ 11.78M$ 21.38M$ 103.97K
Total Assets$ 32.43M$ 17.89M$ 25.73M$ 33.55M$ 12.24M
Total Debt$ 21.29M$ 0.00$ 0.00$ 0.00$ 1.57M
Net Debt$ 4.80M$ -3.97M$ -11.78M$ -21.38M$ 1.47M
Total Liabilities$ 56.58M$ 52.81M$ 51.66M$ 25.07M$ 15.31M
Stockholders Equity$ -24.15M$ -34.92M$ -25.94M$ 8.49M$ -15.12M
Cash Flow-
Free Cash Flow$ -13.48M$ -10.93M$ -9.55M$ -40.60M$ -9.26M
Operating Cash Flow$ -13.42M$ -10.87M$ -8.85M$ -40.18M$ -9.23M
Investing Cash Flow$ -60.00K$ -66.00K$ -700.00K$ -9.54M$ -30.00K
Financing Cash Flow$ 25.99M$ 3.13M$ 43.00K$ 61.74M$ 6.40M
Currency in USD

TriSalus Life Sciences Earnings and Revenue History

TriSalus Life Sciences Debt to Assets

TriSalus Life Sciences Cash Flow

TriSalus Life Sciences Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis